Status:
UNKNOWN
Intraureteral Lidocaine for Post-Ureteroscopy Pain
Lead Sponsor:
Queen's University
Conditions:
Ureteral Calculi
Renal Calculi
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Ureteroscopy (URS) is minimally invasive procedure for management of renal stones. URS is often involves concomitant of an indwelling ureteral stents. Placements of these stents include pain, bladder ...
Detailed Description
Patients treated with ureteroscopy (URS) for ureteral or renal calculi requiring a ureteral stent at time of URS will be randomized to receive intraureteral instillation of alkalinized lidocaine hydro...
Eligibility Criteria
Inclusion
- Patient undergoing URS for treatment of a urinary calculus who requires placement of ureteral stent on a string
- Able to undergo a general anaesthetic
- At least 18 years old
- Willing and able to complete patient symptom questionnaires
Exclusion
- Solitary Kidney
- Renal failure
- Anatomic bladder or ureteral abnormality
- Uncorrected coagulopathy
- Previous cystectomy or urinary diversion
- Neurogenic bladder
- Interstitial cystitis
- Transplanted kidney
- Pregnancy
- Requires an indwelling catheter
- Recurrent urinary tract infections
- Requires an indwelling stent
- Pelvic kidney
- Requires bilateral treatment/stents
- Previous bladder or ureteral reconstructive surgery
- Ureteral perforation during procedure
- Ureteral stenting, within one month of URS
- Known sensitivity to lidocaine
- Febrile at time of randomization or treatment
- Requires spinal anaesthetic
Key Trial Info
Start Date :
September 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2013
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT01450566
Start Date
September 1 2011
End Date
December 1 2013
Last Update
November 6 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre for Applied Urological Research/Kingston General Hospital
Kingston, Ontario, Canada, K7L 2V7